The Thymic Origin of the Plasma Lymphocytosis Stimulating Factor by Metcalf, D.
442
THE THYMIC ORIGIN OF THE PLASMA LYMPHOCYTOSIS
STIMULATING FACTOR
D. METCALF*
From The Walter & Eliza Hall Institute of Medical Research, Royal Melbourne Hospital,
Parkville, N.2, Victoria, Australia.
Received for publication July 13, 1956
IT was shown (Metcalf, 1956a, 1956b) that the plasma from several disease
states was capable ofinducing a lymphocytosis when inoculated into baby mice.
The disease states, in which this plasma activity was detected, were: chronic
lymphatic leukaemia, lymphosarcoma and myelofibrosis.
Certain factors influencing this plasma lymphocytosis stimulating factor were
also noted. Plasma activity was depressed during natural remissions and follow-
ing transfusions of whole blood. Plasma activity rose following intramuscular
injections ofadrenalin. Thelymphocytosis effect in inoculated mice was inhibited
by pre-heating of the plasma to 60° C. or by the concurrent administration of
cortisone or oestrogen.
To elucidate the relationship between the plasma factor and the disease states
in which it is found, an attempt was made to determine the organ or organs
producing or storing this factor.
It has been found that emulsions of normal human thymus tissue possess a
lymphocytosis stimulating activity when injected into baby mice. Mouse thymus
emulsions show similar activity.
This thymic substance is closely related to, or identical with the lympho-
cytosis stimulating factor found in the plasma of the above-mentioned disease
states.
Preliminary investigations have shown that the thymus in these disease
states has a higher than normal content of lymphocytosis stimulating material.
MATERIAL AND METHODS
Human material
Specimens from normal human organs were obtained during autopsies on
persons dying from accidental causes. Similar specimens were also obtained from
patients dying from chronic lymphatic leukaemia and lymphosarcoma.
In all cases the material was obtained within twelve hours of death.
All specimens were removed by a no-touch technique using sterile instruments.
Organ emulsions were prepared from these specimens by grinding 0.25 g. of
the tissue with sterile silica in pestle and mortar. The ground tissue was then
emulsified to a final dilution of 1: 20 using sterile normal saline with added
penicillin and streptomycin (25 units of each per ml.).
The emulsions were centrifuged at 3000 r.p.m. for five minutes to remove the
silica andlarge cellular debris. Thesupernatant fluidwas either usedimmediately
or stored at -20° C.
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Mouse material
Mice used were those of the Hall Institute stock. Standard 1: 20 organ
emulsions were prepared as described above from both normal mice and mice
with naturally occurring chronic lymphatic leukaemia.
Test mice
The mice used for testing the activity of organ emulsions were again those of
the Hall Institute stock. These mice have been interbred for a number of years,
but are by no means genetically homozygous.
Method of testing
Organ emulsions fromthe above sources were tested for lymphocytosis stimula-
ting activity in the following manner.
Three litters of 1-2 day old mice (18 mice) were used for each organ emulsion
tested.
Each mouse was inoculated intracerebrally with 0.03 ml. of organ emulsion
using 0-25 ml. graduated syringes and Gauge 25 or 26 needles. Injections were
made midway between the eye and the ear.
The mice were then returned to their mothers. Six days after inoculation,
white cell counts were performed on all mice using blood obtained from the tail,
by cutting off the tip of the tail with a pair of sharp scissors.
The flow of blood produced by this method can be regulated by the firmness
with which the hind quarters of the mouse are held.
Rapidly-spread blood films were prepared, stained with Leishmann's stain
and differential white cell counts made according to a standard pattern. The
lymphocyte/polymorph ratio was calculated and the mean L/P ratio ofthe group
of 18 mice determined.
Absolute white counts where performed, were done in standard fashion using
a modified Levy haemocytometer.
The heart blood ofthe mouse contains many fewer white cells per unit volume
thanthe peripheral blood (Fekete, 1941). This fact is ofimportance when dealing
with baby mice where the total blood volume is small.
Absolute white cell counts and blood films should, therefore, be made from the
first drop of blood obtained from the tail. In addition, the white cell diluting
pipette should be filled first to minimise the variability of results when the heart
blood dilutes the peripheral blood.
Absolute white cell counts cannot be repeated on any one mouse because of
these considerations. Further, the mice appear to develop a brisk polymorpho-
nuclear leucocytosis in response to the trauma of tail-cutting. This renders
meaningless any subsequently performed differential white cell count.
Despite these apparent limitations the method of estimation is simple and
capable of giving reproducible results.
Calculation oforgan content of L.S.S.
Where a standard 1: 20 organ emulsion was found to have a lymphocytosis
stimulating activity, an estimation of the organ content of this lymphocytosis
stimulating substance (L.S.S.) was carried out in the following manner.
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Serial dilutions of the organ emulsion were tested and the highest dilution,
at which a lymphocytosis could be produced, was determined.
The organ content ofL.S.S. was then calculated in mouse units, where 1 mouse
unit (M.U.) = 0-03 ml. of highest dilution of the organ emulsion producing a
lymphocytosis. For example, if 0.25 g. of an organ weighing 1 g. was found to
induce a lymphocytosis at a dilution of 1/250, then
Total organ content of L.S.S. = 0.25 x 250 x 30M.U. = 30,000 mouseunits.
Tissue cultures
Maitland type tissue cultures of mouse thymus were prepared in the following
manner.
Mice were killed by beheading and the thymuses were removed aseptically and
washed in Earle's solution.
The thymuses were coarsely minced with sharp scissors and transferred to
5 x I inch roller tissue culture tubes.
The number of thymuses per tube was either three 8-day thymuses or ten
2-day thymuses.
Two ml. of nutrient fluid were then added to each tube. The composition of
this fluid was;
Earle's Solution
Penicillin
Streptomycin 50 Units of each per ml.
The tubes were rotated at 60 r.p.hour at 36° C.
RESULTS
Lymphocytosis stimulating activity of various human and mouse tissues
As a preliminary screening procedure, saline emulsions of various human and
mouse organs were prepared at a standard 1: 20 dilution. These emulsions were
then injected into groups of eighteen 2-day old mice and the mice examined six
days later.
The presence or absence of alymphocytosis for mice ofthis age was determined
by performing absolute and differential white cell counts on tail blood. The
upper limits of the normal white cell count for mice of this age have been
established as a totallymphocyte count of 2500 per cu.mm. and a lymphocyte/
polymorph ratio of 3.0 (Metcalf, 1956a).
As cases of chronic lymphatic leukaemia in man and mice became available,
organs from these sources were also screened in the above fashion.
The results obtained are presented in Table I.
It may be geen that, ofthe normal human and mouse organs tested, only two,
the thymus and the thyroid, showed any lymphocytosis stimulating activity.
This held also for those cases of chronic lymphatic leukaemia which were
examined. However, in these cases, the plasma or serum also exhibited a
lymphocytosis stimulating activity.
The lymphocytosis following injections of thyroid emulsions was only slight in
degree. For reasons to be discussed later, it appears likely that the effect occurred
as a secondary phenomenon due to stimulation by the thyroid emulsion of the
inoculated mice's own thymus glands.
444ORIGIN OF LYMPHOCYTOSIS STIMULATING FACTOR
Type oftissue.
Normal human
Normal mouse
Chronic
Lymphatic
Leukaemic
Human
Chronic
Lymphatic
Leukaemic
Mouse
TABLE I.
Tissues showing
lymphocytosis
stimulating activity.
Thymus
Thyroid
Thymus
Thyroid
Thymus
Plasma or serum
Thyroid
Thymus
Serum
Thyroid
Tissues showing no
lymphocytosis
stimulating activity.
Plasma or serum
Lymph Node
Liver
Spleen
Heart
Lung
Adrenal
Bone marrow
Brain
Pituitary
Kidney
Serum
Lymph node
Liver
Spleen
Heart
Lung
Kidney
Brain
Lymphocytes
(circulating)
Lymph node
Leukaemic masses
Liver
Spleen
Heart
Lung
Adrenal
Bone marrow
Brain
Pituitary
Kidney
Lymph node
Leukaemic masses
Liver
Spleen
Heart
Lung
Brain
Kidney
Emulsions of organs other than the thymus and the thyroid did not alter the
peripheralbloodpicturefromnormalwiththeexception ofadrenalglandemulsions
which produced a lymphopenia.
A brief survey of normal human thymuses from persons of various ages was
carried out. This revealed that thymus tissue at all ages possesses a lympho-
cytosis stimulating activity for mice. However, the total thymic content of the
lymphocytosis stimulating substance (L.S.S.) fell considerably withadvancing age.
The thymic L.S.S. content of a small series of children varying in age from
several days to one year, was estimated at approximately 200,000 mouse units
(1 mouse unit = 0-03 ml. of the highest dilution of thymus emulsion showing
lymphocytosis stimulating activity).
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The thymus was not always demonstrable in elderly people. Where definite
thymic tissue could be demonstrated by naked eye dissection, the L.S.S. content
was found to be in the region of 1500 M.U.
This survey ofhuman thymuses was not pursued exhaustively due to the large
number of mice needed for estimating the activity of each dilution of thymus
emulsion. However, it was established beyond doubt that the normal human
thymus contains a substance (L.S.S.) capable of producing a lymphocytosis in
baby mice, and that the thymic content of L.S.S. decreased with advancing age.
Similar titrations were performed on normal mouse thymuses. Here the
situation was somewhat different. The thymic content of L.S.S. in the newborn
mouse was very low (< 2 M.U.). During the first week of post natal life, the
thymic content rose sharply reaching the maximum in young adult life (> 3
months). Thereafter the thymic content decreased to levels of the order of
100 M.U.
The increasing thymic content of L.S.S. during the first week of life was of
interest, as it is during this period that the peripheral blood picture of the mouse
changes from a polymorphonuclear one to one showing a preponderance of
lymphocytes.
A preliminary investigation of the thymus in chronic lymphatic leukaemia
inbothman and mice has shownthatthereis a considerably higher thymic content
of L.S.S. than in comparable normal thymuses.
These results have been set out in Fig. 1 and 2.
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FIG. 1.-Total thymic contents of lymphocytosis stimulating substance (L.S.S.) expressed
logarithmically in mouse units. Each column represents a single mouse.
Fig. 1 shows the total thymic L.S.S. content of a number of leukaemic mice
and a comparable group of normal mice of the same age. Thymic titres are
expressed in mouse units on a logarithmic scale, each column representing a
single mouse.
Fig. 2 shows the results obtained from a similar survey of human cases of
chronic lymphatic leukaemia. In this instance, due to considerable variation in
the ages ofthe patients, the thymic L.S.S. titres have been compared individually
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with normal thymus L.S.S. titres of persons of the same age and sex. The first
and third cases were aged 60 years and the second 35 years. It may be seen that,
for the younger pair, the total thymic L.S.S. content of both the normal and
leukaemic person was high.
In the human cases, the effect of therapeutic procedures, particularly irradia-
tion, on the histology and function of tissues in the thymic area, made an
assessment of previous thymus function difficult.
In some cases, dense fibrotic tissue in the thymic region made it impossible to
identify and dissect free the thymus.
For this reason, the survey was limited to cases which had had no previous
therapy directed to the mediastinal area.
6-0
ri 5*O
ui 45.0
. 4.0
2.0
1 l.0
N L N L N L
FIG. 2.-Total thymic contents of lymphocytosis stimulating substance (L.S.S.) expressed
logarithmically in mouse units. Each column represents a single case. L = Chronic
lymphatic leukaemia. N = Normal humans of same age and sex.
In both the uncomplicated human cases and the leukaemic mice, the thymus
'was larger than normal, sometimes markedly so. However, the variable extent
to which the gland was infiltrated with lymphocytic tissue, made it difficult to
assess the mass of the thymic tissue proper.
No answer could, therefore, be obtained on the question of whether the higher
than normal total thymic L.S.S. content was due to a greater thymic cell mass
or a higher concentration of L.S.S. per cell.
The increased thymic content of L.S.S. in chronic lymphatic leukaemia is of
obvious interest in regard to the relationship between thymic L.S.S. and the
lymphocytosis stimulating factor detectable in the plasma ofthese patients.
Before definite conclusions can be drawn however, the observations on elevated
thymic L.S.S. titres need confirmation and amplification with a larger series.
Production of L.S.S. by thymicfragments in tissue culture
Tissue culture experiments using normal mouse thymus were performed in an
attempt to determine whether the thymus tissue was actually producing this
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L.S.S. or merely acting as a storage organ for material produced elsewhere in
the animal.
Thymuses were removed aseptically from normal 7 day-old and 2 day-old
mice and coarsely minced with sharp scissors. The thymic fragments were
rinsed in Earle's solution and set up in roller type Maitland tissue cultures as
described above.
After 24 hours incubation in the case of the 7 day-old thymuses and 5 days
incubation for the 2 day-old thymuses, the tubes were removed from the
incubators.
The tissue culture fluids were removed and the thymus fragments were
emulsified in normal saline. Both sets of material were then tested for L.S.S.
and, ifdetectable, thetitrewas estimated byserial dilution oftheoriginal material.
Control 7-day and 2-day thymuses were titrated for L.S.S. content in the
standard fashion.
The results obtained are listed in Table II. In the post-incubation column
are shown the combined total titre of tissue fragments and tissue culture fluid.
TABLE II.-Mouse Thymus Tissue Culture
Pre-incubation Post-incubation
Type of Days of titre in mouse titre in mouse
thymus. incubation. units. units.
7-day thymus . . 1 . 500 . 3000
2-day thymus. . 5 . <6 . >120
2-day thymus. . 5 . <6 . >120
2-day thymus . . 5 . <6 . >120
It may be seen that a definite rise in total thymic content of L.S.S. occurred
following tissue culture particularly in those cultures carried on for five days.
This presumably was the result of an actual production of L.S.S. by the thymus
tissue fragments.
Secretion of L.S.S. from the thymus fragments into the overlying tissue
culture fluid appeared to have taken place, as in each instance, approximately
50per cent ofthe combined post incubation L.S.S. was present in thetissue culture
fluid. However, this could equally well have been the result of the considerable
shedding ofintact and damaged thymic cells into the overlying fluid which occurs
during this type of tissue culture.
Type of thymic cell producing L.S.S.
An attempt was made to identify the thymic cell type producing the L.S.S.
detectable in human and mouse thymuses.
The thymus contains two main cell types-small round cells with the morpho-
logical appearance oflymphocytes and larger epithelial type cells.
Thymic tissue also contains a network of reticulum cells but this tissue was
considered unlikely as the source ofthe L.S.S. in view ofthe absence ofdetectable
L.S.S. in lymph nodes and splenic tissue.
The mouse thymus is suitable for an approach to this problem because of the
arrangement ofthymic tissue into a sharply defined cortex ofsmall round cells and
a medulla ofthe large epithelial cells.
Mouse thymuses were removed and frozensolidinPetri dishes placed on blocks
of dry ice. In this rigid state it was possible to shave off cortical tissue with a
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sharp scalpel. Histological check of these cortical shavings showed no
contaminating medulla cells.
It was not possible by this method to obtain medullary tissue free from cortical
cells.
Pooled fragments of cortical tissue and medullary tissue with cortical
contamination were emulsified and assayed for L.S.S.
Table III shows that whilst the medulla fragments were quite active, the pure
cortical emulsions showed no activity.
The implication is strong that the epithelial cells ofthe thymus are the source
of the L.S.S. in this organ.
However, the possibility that cortical cells may play an associated role in the
production of L.S.S., although unlikely, has not been excluded.
TABLE III.
Lymphocytosis
stimulating activity.
L/P ratios of
No. of inoculated mice
Mouse thymus. experiment. (normalrange = 2-0-3- 1).
Cortex . . { I 25 II 2.8
Medulla + cortical fragments . { II 4
Relationship between plasma L.S.F. and thymus L.S.S.
The thymus in eight day mice normally contains detectable amounts of L.S.S.
No detectable thymus L.S.S. could befound, however, in eight day mice which
had been injected at the age of two days with a lymphocytosis stimulating
inoculum of mouse thymus emulsion.
This apparent depression ofthymus activity was also found to occur following
inoculations ofhuman thymus emulsions. More importantly, the same effect was
found to have occurred following inoculations of plasma containing the
lymphocytosis stimulating factor (L.S.F.).
On the other hand, inoculations of non-active human plasma, emulsions of
other organs or thymus emulsions diluted beyond the limit of the L.S.S. titre,
produced no alteration in the thymus L.S.S. content ofthe inoculated mice.
The method used to demonstrate this effect was as follows. Groups of six,
2 day old mice were injected with inocula of various types. Examination of the
peripheral blood at the age ofeight days was performed to determine the presence
or otherwise of a lymphocytosis.
The thymuses were then removed from these mice, emulsified in normal
saline to a standard 1: 20 dilution and tested for lymphocytosis stimulating
activity in a further series of baby mice.
The results obtained are recorded in Table IV. The presence of a lympho-
cytosis or otherwise was determined by calculating the mean valuefor thelympho-
cyte/polymorph ratio in the peripheral blood of each group of mice on the sixth
post-inoculation day. A ratio greater than 3-1 indicates a lymphocytosis
(Metcalf, 1956a).
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TABLE IV.
L/P ratios following
inoculation of
No. of mice thymus emulsions
Origfh of No. of used for (normal range
thymic tissue. experiment. estimation. 2-0-3.1).
I . 20 4.0
Normal 8-day mice . . II . 18 4 2
III . 12 4-1l
Mice inoculatedwithinactive . 12 . 44
tissue emulsions I 14 34
18 4.0
Miceinoculatedwithinactive f I . 12 . 5.7
human plasma II . 14 . 4.2
f I . · 12 2.5 Mice inoculated with human . 12 . 25
F I . 18 . 2.9
Mice inoculated with mouse J II . 15 . 286
thymus emulsions III . 12 . 25
IVII . 18 . 3215
I . 12 . 2.2 Mice inoculated with active II . 15 . 2.7
human chronic lymphatic III . 25 . 2.6
leukaemic plasma IV . 16 . 3.0
V . -16 . 2.7
It may be seen from the table that active leukaemic plasma and thymus
extracts were equally effective in depressing the thymic content of L.S.S. of the
inoculated mice.
A histological examination of these thymuses was made in an attempt to find
a morphological basis for the different activity of the thymuses from inoculated
and uninoculated mice.
Thymuses from both groups were fixedinCa&noy's fixative and aftersectioning
were stained with haematoxylin and eosin, Periodic Acid-Schiff, Masson's stain
and Scharlach R (frozen sections).
No constant difference could be detected between the two groups with regard
to cell types, cell numbers, mitotic activity or the presence or absence ofsecretion
products.
There was no difference in gross thymic weights between the groups.
It was of interest to determine how long the depression of thymus L.S.S.
content lasted, both in the body and when removed to tissue culture conditions.
It was found, by daily testing of thymus emulsions from suitably inoculated
mice, that the thymic content of L.S.S. returned to a near-normal level by the
twelfth day of age, that is, ten days after the original inoculation.
The effect oftissue culture on the thymic L.S.S. content in inoculated mice was
determined in the following manner.
Thymuses were removed from mice previously inoculated with thymus
emulsions or active chronic lymphatic leukaemic plasma.
Pools of six thymuses were used in each experiment. The thymuses were
divided into halves and one group of halves tested immediately for L.S.S.content.
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The other group of halves was cultured in roller tubes for 24 hours as described
above. Then, both the tissue culture fluid and an emulsion of the thymus tissue
culture were tested for L.S.S.
It was found that, within twenty four hours, the tissue-cultured thymuses
from such animals had regained detectable amounts of L.S.S.
These results are shown in Table V.
TABLE V.
L/P ratios of inoculated mice
(normal limits 2 -0-3* 1).
Tissue
cultured Tissue
No. of Thymus thymus culture
Source of No. of mice per tested after fluid after
thymus. experiment. estimation. immediately. 24 hours. 24 hours.
Mice inoculated with active I . 18 . 2 6 3
- 9 30
chronic lymphatic leu- II . 18 . 30 3 6 4 2
kaemic plasma III . 15 . 2 7 3-3 3-.9
F I . 16 . 2-9 3- 9 3-8
Mice inoculated with active II . 15 . 2 5 3-6 -
thymus emulsions III 18 3.1 4 2
IV 18 . 2.5 3-2
It may be seen, therefore, that when the thymuses, showing no detectable
L.S.S., were removed from the milieu of the inoculated mice, they rapidly
produced detectable quantities of L.S.S.
Experiments were next performed to determine whether or not thymuses with
depressed contents ofL.S.S. could produce L.S.S. in tissue culture in the presence
of active L.S.S. material
The method used was similar in its essentials to the one just described, but in
addition tissue cultures of depressed thymuses were set up to which 0-1 ml. of an
active 1: 20 thymus emulsion had been added.
As a control, tubes were also set up containing splenic tissue with and without
added thymus emulsion, to guard against the possibility ofnon-specific adsorption
of L.S.S. from the tissue culture fluid.
Control tubes of normal mouse thymus with and without added thymus
emulsion were also set up.
After twenty-four hours incubation, the respective tissues were removed from
the tubes, washed three times with 5 ml. ofsterile saline, and emulsified in normal
saline to produce 1; 20 emulsions.
These emulsions were then tested in groups of 18 mice for ability to induce a
lymphocytosis.
Table VI shows the results obtained. A mean lymphocyte/polymorph ratio
greater than 3-1 indicates presence in the inoculated mice of a lymphocytosis.
It may be seen firstly, that the addition ofthymus emulsion to tissue cultures
ofnormal thymus did not affect the final L.S.S. content ofthe tissue. Secondly,
there appeared to be no non-specific adsorption of L.S.S. from the tissue culture
fluid by the splenic tissue cultures
However, it will be observed that, whereas the depressed thymuses produced
L.S.S. in tissue culture, they did not do so if the tissue culture fluid contained
added thymus extract.
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TABLE VI.-Lymphocyte/Polymorph Ratios of Mice Inoculated with Tissues
after Tissue Culturefor 24 hours.
Normal Normal Inoculated
thymus spleen thymus
Experiment Normal + thymus Normal + thymus Inoculated + thymus
No. thymus. emulsion. spleen. emulsion. thymus. emulsion.
I . 4-0 . 3-6 . 2-4 . 2-6 3-6 . 2-6
III . 4-1 . 4-2 . 2-9 . 30 . 4-2 . 2-5
III . 4.3 . 40 . 2-7 . 2-7 . 3-6 . 2-7
The above results may be summarised as follows. The inoculation oftwo day
mice with lymphocytosis stimulating material in the form of human plasma or
human or mouse thymus causes, in addition to the lymphocytosis, a temporary
inhibition of the development of the normal thymic content of L.S.S. in the
inoculated mice. These thymuses rapidly develop a normal content of L.S.S. in
tissue culture, but fail to do so if thymus emulsion is added to the tissue culture
fluid.
These findings have been shown schematically in Fig. 3. ·~~~~~
Level ofdetection
ofthymusL.S.S.
4.)
I I I I I I I I I I
1 2 3 4 5 6 7 8 9 10 11
Days ofage
FIG. 3.-Schematic representation of the development of thymic L.S.S. in normal and
inoculated mice.
A = Normal development ofthymic L.S.S.
B =Development of L.S.S. following inoculation of active L.S.S. material.
B1 = Tissue culture of B thymuses.
B2 -Tissue culture of B thymuses with added thymus extract.
One possible interpretation of this phenomenon is as follows. The thymus in
2 day mice is in an early developmental phase during which it contains very little
L.S.S.(< 2M.U.). Normally, perhapsinresponseto demandsfromthedeveloping
animal, this amount would rise during the first week of life. However, in the
inoculated-mice, these demands may be met, for a time, by the L.S.S. content
of the inoculum. The animals' own thymic tissue, having a lessened functional
demand made on it, fails to develop the increase in thymic L.S.S. as rapidly as
normal mice.
This situation may be made to persist in tissue culture if the fluid milieu of
the cells is made similar to that existing in the inoculated animal, by the
addition of the thymus emulsion to the tissue culture fluid.
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The phenomenon may thus represent an example of control of the functional
development and activity of an organ by the exhibition of extracts ofthat organ.
Similar examples in other organs have been described by Galli-Mainini (1941,
1942) for the thyroid, de Robertis (1940, 1941) for the parathyroid, Kendall (1941,
1942) for the adrenal and by Weiss(1950).
Apart from these considerations, two points were of considerable theoretical
interest:
(a) the similar depressing effect of thymus emulsions ofhuman and mouse
origin-indicating that the active material concerned was
functionally similar in both species;
(b) the similar depressing effect of plasma from disease states showing
plasma lymphocytosis stimulating activity-again suggesting a
close functional similarity between the plasma factor and the thymic
substance.
This phenomenon has also provided a means of distinguishing between the
lymphocytosis stimulating effect of thymus and thyroid emulsions.
As has been described above, thelymphocytosis induced bythymic emulsions is
attended by a depression in the thymic content of L.S.S. in the inoculated mice.
When mice are inoculated with thyroid emulsions, a moderate lymphocytosis
is produced. However, when the thymus glands of inoculated mice were
examined, they were found to have a normal content ofL.S.S. These findings are
set out in Table VII.
TABLE VII.-Lymphocyte/Polymorph Ratios in Mice Inoculated with
Thymus Emulsions of Various Origins
Lymphocyte/polymorph
No. of mice ratios following
Origin of thymic used for injection of
tissue. estimation. thymus emulsions.
12 . 2.5
Mice inoculated with thymus emulsions 18. 2-6 { 18 . 2-5
16 . 3.9
Mice inoculated with thyroid emulsions 18 . 3.3 { 16 . 4.0
These findings have been interpreted as indicating that the lymphocytosis
occurringfollowinginoculations ofthyroidemulsions is a secondary effect resulting
from a stimulation of the inoculated mice's own thymuses to greater production
of L.S.S.
Effect of heat and oestrogens on thymus L.S.S.
It was noted, Metcalf (1956b) that the lymphocytosis following inoculations of
active leukaemic plasma samples could be inhibited by preheating the plasma to
60° C. for 15 minutes or by the concurrent administration of oestrogens (50 i.u.
oestradiol benzoate per mouse).
When thymic emulsions were subjected to these two procedures, it was found
that the lymphocytosis effect was again inhibited.
This is shown in Table VIII.
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TABLE VIII.-Lymphocyte/Polymorph Ratios in Inoculated Mice
(normal L/P ratio 2.0-3-1)
Lymphocyte/polymorph
Type of inoculum. ratio.
Human thymus emulsion . . . . . 40
4-1
Human thymus emulsion heated to 60° C. for 15 minutes . 30
2-7
Human thymus emulsion and oestrogen . . . . 2.2
These findings again indicate the close similarity between the plasma factor
and thymic L.S.S.
DISCUSSION
Using baby mice as the test animal, emulsions ofvarious normal andleukaemic
organs have been tested for lymphocytosis stimulating activity.
Ofthe organs tested, only two have shown such activity-the thymus and to a
lesser degree the thyroid.
The finding that thymus tissue contains alymphocytosis stimulating substance
is in accord withthe earlier work ofBomskov and Sladovic (1940). These workers
found that oily extracts of normal thymus produced a lymphocytosis when
inoculated into rats, guinea pigs and pigeons.
Rehn (1940) has shown that similar preparations can produce a lymphocytosis
in man.
Bomskov and Sladovic claimed that the active substance was produced by the
epithelial type cells of the thymus, incorporated in lymphocytes and carried
throughout the body in this manner.
The present findings have confirmed that the epithelial type cells ofthe mouse
thymus medulla contain such a lymphocytosis stimulating substance (L.S.S.).
However, neither thymus cortical tissue, lymphocytes, lymphnodes or spleen have
been shown to have any activity.
Furthermore, in those disease states in which the plasma showslymphocytosis
stimulating activity, preparations of lymphocytes, lymphnodes and leukaemic
masses are again inactive.
The implication is that the substance found in the thymic epithelial cells is
carried throughout the body in the plasma and not the lymphocytes.
Preliminary results have confirmed Bomskov and Sladovic's (1940) claim that
young animals have a higher thymic content of L.S.S. than older animals. This
has been found to be the case both for mice and humans.
This does not necessarily indicate that the L.S.S. content per cell is higher
in the young animal as the thymic cell mass ofepithelial cells is very much higher
in the young animal.
Maitland-type tissue cultures of mouse thymus have been shown to produce
L.S.S. and there appears to be little doubt that the thymus is actually producing
this material and not merely storing a substance produced elsewhere inthe animal.
The finding that thymic L.S.S. is contained in the epithelial type cells of the
mouse thymus throws light on the observations of Hammar (1931) on the
corresponding Hassall's corpuscles of the human thymus. He found that in
conditions leading to a lymphocytosis, hyperplasia of the Hassall's corpuscles
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occurred, followed after an interval by hyperplasia of the lymph node follicles
and finally by the appearance of a lymphocytosis.
The original purpose of the present investigation was to determine the tissue
producing the lymphocytosis stimulating factor found in the plasma of certain
disease states-particularly chronic lymphatic leukaemia and lymphosarcoma.
The present work has shown that the thymus produces a lymphocytosis
stimulating substance, both in normal and leukaemic animals and the evidence
indicates the identity of thymic L.S.S. and the plasma factor. The features
shown in common by the two are:
(a) production of a lymphocytosis in baby mice,
(b) inhibition of the developmenlt of a normal thymic L.S.S. content in
inoculated mice,
(c) inhibition of activity by heating to 60° C.,
(d) inhibition of activity by the concurrent administration of cortisone or
oestrogens.
Of these, the inhibition of the development of thymic L.S.S. is probably the
most specific. Both plasma L.S.F. and thymic L.S.S. produce a lymphocytosis
in inoculated mice whilst at the same time inhibiting the functional activity of
the thymus in producing L.S.S. In the light of present knowledge of endocrine
interrelationships, this finding can only indicate that both lie in a functional
position between the originating endocrine gland and the target cell. Since one
of the two, thymus L.S.S., is known to be produced by the thymus, then
presumably both are.
The phenomenon of suppression of the thymic content of L.S.S. has enabled
the lymphocytosis stimulating effects of thymus and thyroid emulsions to be
differentiated.
Thyroid emulsions, although producing a lymphocytosis, do not inhibit the
accumulation of L.S.S. inthethymus. It is probable, therefore, that thelympho-
cytosis in this case is produced by a stimulation of the mouse's own thymus to
produce more L.S.S.
This concept is supported by Boyd's (1932) observation that a constant
thymic hyperplasia is found in patients suffering from hyperthyroidism. The
common clinical observation of a relative or absolute lymphocytosis in hyper-
thyroidism may find its explanation in these interrelationships.
From the above evidence for the close similarity between plasma L.S.F. and
thymic L.S.S., it might be expected that the thymic content of L.S.S. would be
raised in those diseases where L.S.F. was detectable in the plasma.
Preliminary observations on the thymuses of patients and mice with chronic
lymphatic leukaemia have confirmed this expectation.
In the small series of thymuses examined, the thymic content of L.S.S. in the
leukaemic animals has been consistently higher than the normal level. This
finding needs confirmation with a larger series but at the moment it gives further
support to the concept that plasma L.S.F. and thymic L.S.S. are identical.
The possibility remains that a deficient breakdown or elimination of thymus
L.S.S. from the body may be responsible for the presence of detectable L.S.F. in
the plasma and raised levels of L.S.S. in the thymus.
However, the finding of Miller and Turner (1943) oflarge amounts oflympho-
cyte stimulating materialinthe urine ofpatients with chroniclymphaticleukaemia
makes this alternative unlikely.
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There is thus good evidence for the presence ofthymus overactivity in patients
and mice with chronic lymphatic leukaemia and lymphosarcoma. What
relationship has this finding to the disease states themselves?
Two possibilities seem to exist:
(a) the thymus overactivity represents a compensatory effort on the part
ofthe body to maintain a normal complement oflymphocytic tissue
in a situation where much ofthepre-existing tissue has been rendered
functionally inadequate by disease:
(b) the thymus overactivity may be aetiologically related to the disease
states. Continued thymus overactivity may, by causing prolonged
stimulation of the lymphocyte tissue, lead to a hyperplasia or
eventual neoplasia of this tissue-either of which may constitute
what is regarded as the leukaemic state.
There is little evidence to support the first hypothesis. However, several
workers have produced evidence indicating that the second possibility may be
correct.
Furth (1952), has shown that thymectomy reduces the incidence oflymphatic
leukaemia in high-leukaemia strain mice. Similarly, Law and Miller (1950) and
Kaplan(1950) have shown that thymectomy reduces the incidence of carcinogen-
and radiation-induced leukaemia in mice.
Conversely, Law (1952) has shown that grafting of thymuses from high
incidence strain mice to low incidence strain mice produces a definite elevation in
the incidence ofleukaemia in grafted mice.
Finally, it has been shown by Weymouth et al. (1955) that thymic tissue in
irradiated mice contains an elevated level ofRNA as compared with normal mice.
There is therefore considerable evidence to relate carcinogen- and radiation-
induced leukemogenesis as well as genetically conditioned leukemogenesis with
aberrations in thymic function. The evidence presented in this paper on thymic
function in human and mouse leukaemia, indicates that thymic hyperactivity
may represent the final common pathway by which the various leukemogenic
factors induce the leukaemic state.
SUMMARY
1. Thymus and thyroid emulsions of human and mouse origin produce a
lymphocytosis when injected into baby mice.
2. The thymus activity resides in the epithelial type cells.
3. Mouse thymus produces this lymphocytosis stimulating substance (L.S S.)
in tissue culture.
4. The content of L.S.S. in thymuses of humans and mice with chronic
lymphatic leukaemia is much higher than normal.
5. Evidence has been presented that this thymic L.S.S. is identical with the
lymphocytosis stimulating factor found in the plasma of certain disease states,
particularly chronic lymphatic leukaemia and lymphosarcoma.
I am indebted to Sir Macfarlane Burnet, F.R.S. for his helpful advice and
criticism throughout this work. I am also indebted to Dr. E. L. French for his
advice and assistance with the tissue culture experiments.
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Human material was obtained with the assistance of Dr. K. Bowden of the
Crown Law Department andthe staffofthe Pathology Departments of the follow-
ing hospitals; Royal Melbourne Hospital, Royal Children's Hospital, Alfred
Hospital and the Cancer Institute. -
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